Effect of breast cancer resistance protein (Bcrp/Abcg2) on the disposition of phytoestrogens

Molecular Pharmacology

Volumn 72, Issue 4, 2007, Pages 967-975

  Enokizono, Junichi ^a   Kusuhara, Hiroyuki ^a   Sugiyama, Yuichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; CARBON 14; COUMESTROL; DAIDZEIN; GENISTEIN; INULIN; MULTIDRUG RESISTANCE PROTEIN 1; PHYTOESTROGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BRAIN; CELL STRAIN; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG TISSUE LEVEL; FETUS; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STEADY STATE; TESTIS; TISSUE DISTRIBUTION; TRANSCYTOSIS; WILD TYPE;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BASE SEQUENCE; CHROMATOGRAPHY, LIQUID; DNA PRIMERS; FEMALE; MALE; MASS SPECTROMETRY; MICE; MICE, KNOCKOUT; PHYTOESTROGENS; RNA, MESSENGER; TISSUE DISTRIBUTION;

EID: 34748926909     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.107.034751     Document Type: Article

References (38)

1. Adeoya-Osiguwa SA, Markoulaki S, Pocock V, Milligan SR, and Fraser LR (2003) 17beta-Estradiol and environmental estrogens significantly affect mammalian sperm function. Hum Reprod 18:100-107.
2. Adlercreutz H (1995) Phytoestrogens: epidemiology and a possible role in cancer protection. Environ Health Perspect 103 Suppl 7:103-112.
3. Atanassova N, McKinnell C, Turner KJ, Walker M, Fisher JS, Morley M, Millar MR, Groome NP, and Sharpe RM (2000) Comparative effects of neonatal exposure of male rats to potent and weak (environmental) estrogens on spermatogenesis at puberty and the relationship to adult testis size and fertility: evidence for stimulatory effects of low estrogen levels. Endocrinology 141:3898-3907.
4. Bart J, Hollema H, Groen HJ, de Vries EG, Hendrikse NH, Sleijfer DT, Wegman TD, Vaalburg W, and van der Graaf WT (2004) The distribution of drug-efflux pumps, P-gp, BCRP, MRP1 and MRP2, in the normal blood-testis barrier and in primary testicular tumours. Eur J Cancer 40:2064-2070.
5. Bayer T, Colnot T, and Dekant W (2001) Disposition and biotransformation of the estrogenic isoflavone daidzein in rats. Toxicol Sci 62:205-211.
6. Breedveld P, Pluim D, Cipriani G, Wielinga P, van Tellingen O, Schinkel AH, and Schellens JH (2005) The effect of Bcrp1 (Abcg2) on the in vivo pharmacokinetics and brain penetration of imatinib mesylate (Gleevec): implications for the use of breast cancer resistance protein and P-glycoprotein inhibitors to enable the brain penetration of imatinib in patients. Cancer Res 65:2577-2582.
7. Breedveld P, Zelcer N, Pluim D, Sonmezer O, Tibben MM, Beijnen JH, Schinkel AH, van Tellingen O, Borst P, and Schellens JH (2004) Mechanism of the pharmacokinetic interaction between methotrexate and benzimidazoles: potential role for breast cancer resistance protein in clinical drug-drug interactions. Cancer Res 64:5804-5811.
8. Cassidy A, Bingham S, and Setchell K (1995) Biological effects of isoflavones in young women: importance of the chemical composition of soybean products. Br J Nutr 74:587-601.
9. Chang HC, Churchwell MI, Delclos KB, Newbold RR, and Doerge DR (2000) Mass spectrometric determination of Genistein tissue distribution in diet-exposed Sprague-Dawley rats. J Nutr 130:1963-1970.
10. Chen J, Wang S, Jia X, Bajimaya S, Lin H, Tam VH, and Hu M (2005) Disposition of flavonoids via recycling: comparison of intestinal versus hepatic disposition. Drug Metab Dispos 33:1777-1784.
11. Cooray HC, Blackmore CG, Maskell L, and Barrand MA (2002) Localisation of breast cancer resistance protein in microvessel endothelium of human brain. Neuroreport 13:2059-2063.
12. Crespy V, Morand C, Manach C, Besson C, Demigne C, and Remesy C (1999) Part of quercetin absorbed in the small intestine is conjugated and further secreted in the intestinal lumen. Am J Physiol 277:G120-G126.
13. Delclos KB, Bucci TJ, Lomax LG, Latendresse JR, Warbritton A, Weis CC, and Newbold RR (2001) Effects of dietary genistein exposure during development on male and female CD (Sprague-Dawley) rats. Reprod Toxicol 15:647-663.
14. Doerge DR, Churchwell MI, Chang HC, Newbold RR, and Delclos KB (2001) Placental transfer of the soy isoflavone genistein following dietary and gavage administration to Sprague-Dawley rats. Reprod Toxicol 15:105-110.
15. Dym M and Fawcett DW (1970) The blood-testis barrier in the rat and the physiological compartmentation of the seminiferous epithelium. Biol Reprod 3:308-326.
16. Enokizono J, Kusuhara H, and Sugiyama Y (2007) Regional expression and activity of breast cancer resistance protein (ABCG2) in mouse intestine: overlapped distribution with sulfotransferases. Drug Metab Dispos 35:922-928.
17. Fraser LR, Beyret E, Milligan SR, and Adeoya-Osiguwa SA (2006) Effects of estrogenic xenobiotics on human and mouse spermatozoa. Hum Reprod 21:1184-1193.
18. Hirano M, Maeda K, Matsushima S, Nozaki Y, Kusuhara H, and Sugiyama Y (2005) Involvement of BCRP (ABCG2) in the biliary excretion of pitavastatin. Mol Pharmacol 68:800-807.
19. Imai Y, Tsukahara S, Asada S, and Sugimoto Y (2004) Phytoestrogens/ flavonoids reverse breast cancer resistance protein/ABCG2-mediated multidrug resistance. Cancer Res 64:4346-4352.
20. Jonker JW, Buitelaar M, Wagenaar E, Van Der Valk MA, Scheffer GL, Scheper RJ, Plosch T, Kuipers F, Elferink RP, Rosing H, et al. (2002) The breast cancer resistance protein protects against a major chlorophyll-derived dietary phytotoxin and protoporphyria. Proc Natl Acad Sci U S A 99:15649-15654.
21. Kondo C, Suzuki H, Itoda M, Ozawa S, Sawada J, Kobayashi D, Ieiri I, Mine K, Ohtsubo K, and Sugiyama Y (2004) Functional analysis of SNPs variants of BCRP/ABCG2. Pharm Res 21:1895-1903.
22. Kyselova V, Peknicova J, Boubelik M, and Buckiova D (2004) Body and organ weight, sperm acrosomal status and reproduction after genistein and diethylstilbestrol treatment of CD1 mice in a multigenerational study. Theriogenology 61:1307-1325.
23. Lee YJ, Kusuhara H, Jonker JW, Schinkel AH, and Sugiyama Y (2005) Investigation of efflux transport of dehydroepiandrosterone sulfate and mitoxantrone at the mouse blood-brain barrier: a minor role of breast cancer resistance protein. J Pharmacol Exp Ther 312:44-52.
24. Maliepaard M, Scheffer GL, Faneyte IF, van Gastelen MA, Pijnenborg AC, Schinkel AH, van De Vijver MJ, Scheper RJ, and Schellens JH (2001) Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res 61:3458-3464.
25. Matsushima S, Maeda K, Kondo C, Hirano M, Sasaki M, Suzuki H, and Sugiyama Y (2005) Identification of the Hepatic efflux transporters of organic anions using double-transfected Madin-Darby canine kidney II cells expressing human organic anion-transporting polypeptide 1B1 (OATP1B1)/multidrug resistance-associated protein 2, OATP1B1/multidrug resistance 1, and OATP1B1/breast cancer resistance protein. J Pharmacol Exp Ther 314:1059-1067.
26. Mizuno N, Suzuki M, Kusuhara H, Suzuki H, Takeuchi K, Niwa T, Jonker JW, and Sugiyama Y (2004) Impaired renal excretion of 6-hydroxy-5,7-dimethyl-2- methylamino-4-(3-pyridylmethyl) benzothiazole (E3040) sulfate in breast cancer resistance protein (BCRP1/ABCG2) knockout mice. Drug Metab Dispos 32:898-901.
27. Mueller SO, Simon S, Chae K, Metzler M, and Korach KS (2004) Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha (ERalpha) and ERbeta in human cells. Toxicol Sci 80:14-25.
28. Nico B, Quondamatteo F, Herken R, Marzullo A, Corsi P, Bertossi M, Russo G, Ribatti D, and Roncali L (1999) Developmental expression of ZO-1 antigen in the mouse blood-brain barrier. Brain Res Dev Brain Res 114:161-169.
29. Patisaul HB, Luskin JR, and Wilson ME (2004) A soy supplement and tamoxifen inhibit sexual behavior in female rats. Horm Behav 45:270-277.
30. Setchell KD, Brown NM, Zimmer-Nechemias L, Brashear WT, Wolfe BE, Kirschner AS, and Heubi JE (2002) Evidence for lack of absorption of soy isoflavone glycosides in humans, supporting the crucial role of intestinal metabolism for bioavailability. Am J Clin Nutr 76:447-453.
31. Sfakianos J, Coward L, Kirk M, and Barnes S (1997) Intestinal uptake and biliary excretion of the isoflavone genistein in rats. J Nutr 127:1260-1268.
32. Smith AJ, Mayer U, Schinkel AH, and Borst P (1998) Availability of PSC833, a substrate and inhibitor of P-glycoproteins, in various concentrations of serum. J Natl Cancer Inst 90:1161-1166.
33. Tanaka Y, Slitt AL, Leazer TM, Maher JM, and Klaassen CD (2005) Tissue distribution and hormonal regulation of the breast cancer resistance protein (Bcrp/ Abcg2) in rats and mice. Biochem Biophys Res Commun 326:181-187.
34. van Herwaarden AE, Jonker JW, Wagenaar E, Brinkhuis RF, Schellens JH, Beijnen JH, and Schinkel AH (2003) The breast cancer resistance protein (Bcrp1/Abcg2) restricts exposure to the dietary carcinogen 2-amino-1-methyl-6- phenylimidazo[ 4,5-b]pyridine. Cancer Res 63:6447-6452.
35. Watanabe S, Terashima K, Sato Y, Arai S, and Eboshida A (2000) Effects of isoflavone supplement on healthy women. Biofactors 12:233-241.
36. Whitten PL, Patisaul HB, and Young LJ (2002) Neurobehavioral actions of coumestrol and related isoflavonoids in rodents. Neurotoxicol Teratol 24:47-54.
37. Wisniewski AB, Klein SL, Lakshmanan Y, and Gearhart JP (2003) Exposure to genistein during gestation and lactation demasculinizes the reproductive system in rats. J Urol 169:1582-1586.
38. Zhang W, Mojsilovic-Petrovic J, Andrade MF, Zhang H, Ball M, and Stanimirovic DB (2003) The expression and functional characterization of ABCG2 in brain endothelial cells and vessels. FASEB J 17:2085-2087.